Cargando…
Thymosin alpha1 use in adult COVID-19 patients: A systematic review and meta-analysis on clinical outcomes
OBJECTIVE: Thymosin alpha1 (Ta1) is widely used to treat patients with coronavirus disease 2019 (COVID-19), however, its effect remains unclear. This systematic review and meta-analysis aimed to evaluate the effect of Ta1 as a COVID-19 therapy. METHODS: PubMed, EMBASE, the Cochrane library, Web of S...
Autores principales: | Shang, Weifeng, Zhang, Bo, Ren, Yali, Wang, Weina, Zhou, Dengfeng, Li, Yuanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754924/ https://www.ncbi.nlm.nih.gov/pubmed/36527881 http://dx.doi.org/10.1016/j.intimp.2022.109584 |
Ejemplares similares
-
Expression and Hydroxylamine Cleavage of Thymosin Alpha 1 Concatemer
por: Zhou, Liang, et al.
Publicado: (2008) -
A Reappraisal of Thymosin Alpha1 in Cancer Therapy
por: Costantini, Claudio, et al.
Publicado: (2019) -
Thymosin alpha 1: A comprehensive review of the literature
por: Dominari, Asimina, et al.
Publicado: (2020) -
COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections
por: Bellet, Marina M., et al.
Publicado: (2023) -
Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study
por: Liu, Jiao, et al.
Publicado: (2021)